Nectar Lifesciences has informed that the meeting of the Board of Directors of the Company is scheduled on 07/08/2018, to consider and approve the Unaudited Financial Results of the company for the quarter ended on June 30, 2018; to convene the Annual General Meeting of Members of the Company for the financial year 2017-18 and matters related thereto; to fix Book Closure dates for the purpose of Annual General Meeting and Dividend as recommended by the Board of Directors in their meeting held on May 28, 2018. Further, pursuant to Code of Conduct as per Regulation 9 of Securities & Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the trading window of the Company shall stand closed from July 31, 2018 to August 09, 2018.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1858.70 |
Dr. Reddys Lab | 1258.55 |
Cipla | 1559.20 |
Lupin | 2198.25 |
Zydus Lifesciences | 1004.00 |
View more.. |